Form D — Lexaria Bioscience Corp.
0001348362-26-000002 · filed Sep 21, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $113,492
- Reported amount sold
- $113,492
- Minimum investment
- $0
- Investors
- 3
- Sales commission
- $7,944
- Finders' fees
- $0
Issuer
- Name
- Lexaria Bioscience Corp.
- CIK
- 1348362
- Entity
- Corporation
- Jurisdiction
- NEVADA
- Year incorporated
- —
- Address
- 100 - 740 MCCURDY ROAD
KELOWNA, A1 V1X 2P7 - Phone
- 250-765-6424
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Christopher Bunka · DirectorKelowna, A1 Find on LinkedIn ↗
-
John Docherty · Executive OfficerKelowna, A1 Find on LinkedIn ↗
-
Richard Christopher · Executive OfficerKelowna, A1 Find on LinkedIn ↗
-
Michael Shankman · Executive OfficerKelowna, A1 Find on LinkedIn ↗
-
Nicholas Baxter · DirectorKelowna, A1 Find on LinkedIn ↗
-
William Edward McKechnie · DirectorKelowna, A1 Find on LinkedIn ↗
-
ALBERT REESE · DirectorKelowna, A1 Find on LinkedIn ↗
-
Bal Bhullar · DirectorKelowna, A1 Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗